Inflammatory markers and lymphocyte subsets in COVID-19 patients with respiratory bacterial Co-infection: Clinical implications

IF 2.1 4区医学 Q3 INFECTIOUS DISEASES

Diagnostic microbiology and infectious disease Pub Date : 2024-08-31 DOI:10.1016/j.diagmicrobio.2024.116516

Tongtong Guo , Baolin Li , Haojun Huang, Jia Feng, Caihong Ye, Xiaoting Zhan, Qing Luo , Jinbo Liu

引用次数: 0

Abstract

Respiratory bacterial co-infections are frequently observed in COVID-19 patients. This retrospective study analysed clinical data from patients with COVID-19 and respiratory bacterial co-infections compared to those with COVID-19 alone. The findings suggest that inflammatory markers and lymphocyte subsets may be valuable for the early identification of co-infections in COVID-19 patients.

查看原文本刊更多论文

COVID-19 呼吸道细菌合并感染患者的炎症指标和淋巴细胞亚群：临床影响

COVID-19 患者经常合并呼吸道细菌感染。这项回顾性研究分析了 COVID-19 和呼吸道细菌合并感染患者的临床数据，并与单纯 COVID-19 患者进行了比较。研究结果表明，炎症标志物和淋巴细胞亚群对于早期识别 COVID-19 患者的合并感染可能很有价值。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Diagnostic microbiology and infectious disease 医学-传染病学

CiteScore

5.30

自引率

3.40%

发文量

149

审稿时长

56 days

期刊介绍： Diagnostic Microbiology and Infectious Disease keeps you informed of the latest developments in clinical microbiology and the diagnosis and treatment of infectious diseases. Packed with rigorously peer-reviewed articles and studies in bacteriology, immunology, immunoserology, infectious diseases, mycology, parasitology, and virology, the journal examines new procedures, unusual cases, controversial issues, and important new literature. Diagnostic Microbiology and Infectious Disease distinguished independent editorial board, consisting of experts from many medical specialties, ensures you extensive and authoritative coverage.